HMG-CoA Reductase Inhibitors as Immunomodulators: Potential Use in Transplant Rejection

ISSN： 0012-6667

Source： Drugs, Vol.62, Iss.15, 2002-01, pp. : 2185-2191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effect of HMG-CoA reductase inhibitors on chronic allograft rejection

By Jones T.

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 1, 2001-04 ,pp. : 95-109

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic use of HMG-CoA reductase inhibitors: current practice and future perspectives

By Cattaneo Dario Baldelli Sara Merlini Simona Zenoni Stefania Perico Norberto Remuzzi Giuseppe

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1553-1566

Informa Healthcare

Access to resources Recommend Favorite

The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function

By Tesfamariam Belay

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 115-120

Adis International

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors in the Prevention of Stroke

By van Mil A.H.M.

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Comparative Tolerability of the HMG-CoA Reductase Inhibitors

By Farmer J.A. Torre-Amione G.

Drug Safety, Vol. 23, Iss. 3, 2000-09 ,pp. : 197-213

Adis International

Access to resources Recommend Favorite